Literature DB >> 32799367

Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.

Rachel F Buckley1,2,3, Matthew R Scott1, Heidi I L Jacobs4,5, Aaron P Schultz1, Michael J Properzi1, Rebecca E Amariglio1,2, Timothy J Hohman6, Danielle V Mayblyum5, Zoe B Rubinstein5, Lyssa Manning1, Bernard J Hanseeuw1,7, Elizabeth C Mormino8, Dorene M Rentz1,2, Keith A Johnson2,5, Reisa A Sperling1,2.   

Abstract

OBJECTIVE: The goal of this study was to examine sex differences in tau distribution across the brain of older adults, using positron emission tomography (PET), and investigate how these differences might associate with cognitive trajectories.
METHODS: Participants were 343 clinically normal individuals (women, 58%; 73.8 [8.5] years) and 55 individuals with mild cognitive impairment (MCI; women, 38%; 76.9 [7.3] years) from the Harvard Aging Brain Study and the Alzheimer's Disease Neuroimaging Initiative. We examined 18 F-Flortaucipir (FTP)-positron emission tomography (PET) signal across 41 cortical and subcortical regions of interest (ROIs). Linear regression models estimated the effect of sex on FTP-signal for each ROI after adjusting for age and cohort. We also examined interactions between sex*Aβ-PET positive / negative (+ / -) and sex*apolipoprotein ε4 (APOEε4) status. Linear mixed models estimated the moderating effect of sex on the relationship between a composite of sex-differentiated tau ROIs and cognitive decline.
RESULTS: Women showed significantly higher FTP-signals than men across multiple regions of the cortical mantle (p < 0.007). β-amyloid (Aβ)-moderated sex differences in tau signal were localized to medial and inferio-lateral temporal regions (p < 0.007); Aβ + women exhibited greater FTP-signal than other groups. APOEε4-moderated sex differences in FTP-signal were only found in the lateral occipital lobe. Women with higher FTP-signals in composite ROI exhibited faster cognitive decline than men (p = 0.04).
INTERPRETATION: Tau vulnerability in women is not just limited to the medial temporal lobe and significantly contributed to greater risk of faster cognitive decline. Interactive effects of sex and Aβ were predominantly localized in the temporal lobe, however, sex differences in extra-temporal tau highlights the possibility of accelerated tau proliferation in women with the onset of clinical symptomatology. ANN NEUROL 2020;88:921-932.
© 2020 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32799367      PMCID: PMC7581543          DOI: 10.1002/ana.25878

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  44 in total

Review 1.  Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.

Authors:  Vincenza Frisardi; Vincenzo Solfrizzi; Davide Seripa; Cristiano Capurso; Andrea Santamato; Daniele Sancarlo; Gianluigi Vendemiale; Alberto Pilotto; Francesco Panza
Journal:  Ageing Res Rev       Date:  2010-05-02       Impact factor: 10.895

2.  Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.

Authors:  Juan Fortea; Eduard Vilaplana; Daniel Alcolea; María Carmona-Iragui; María-Belén Sánchez-Saudinos; Isabel Sala; Sofía Antón-Aguirre; Sofía González; Santiago Medrano; Jordi Pegueroles; Estrella Morenas; Jordi Clarimón; Rafael Blesa; Alberto Lleó
Journal:  Ann Neurol       Date:  2014-06-13       Impact factor: 10.422

Review 3.  The role of sex in the genomics of human complex traits.

Authors:  Ekaterina A Khramtsova; Lea K Davis; Barbara E Stranger
Journal:  Nat Rev Genet       Date:  2019-03       Impact factor: 53.242

Review 4.  Sex differences in Alzheimer disease - the gateway to precision medicine.

Authors:  Maria Teresa Ferretti; Maria Florencia Iulita; Enrica Cavedo; Patrizia Andrea Chiesa; Annemarie Schumacher Dimech; Antonella Santuccione Chadha; Francesca Baracchi; Hélène Girouard; Sabina Misoch; Ezio Giacobini; Herman Depypere; Harald Hampel
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

5.  Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Authors:  Abhinay D Joshi; Michael J Pontecorvo; Chrisopher M Clark; Alan P Carpenter; Danna L Jennings; Carl H Sadowsky; Lee P Adler; Karel D Kovnat; John P Seibyl; Anupa Arora; Krishnendu Saha; Jason D Burns; Mark J Lowrey; Mark A Mintun; Daniel M Skovronsky
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

6.  Frequency of stages of Alzheimer-related lesions in different age categories.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

7.  Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels.

Authors:  Jessica S Damoiseaux; William W Seeley; Juan Zhou; William R Shirer; Giovanni Coppola; Anna Karydas; Howard J Rosen; Bruce L Miller; Joel H Kramer; Michael D Greicius
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

10.  Sex differences in Alzheimer's disease and common neuropathologies of aging.

Authors:  Shahram Oveisgharan; Zoe Arvanitakis; Lei Yu; Jose Farfel; Julie A Schneider; David A Bennett
Journal:  Acta Neuropathol       Date:  2018-10-17       Impact factor: 17.088

View more
  12 in total

1.  Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.

Authors:  Amaryllis A Tsiknia; Steven D Edland; Erin E Sundermann; Emilie T Reas; James B Brewer; Douglas Galasko; Sarah J Banks
Journal:  Mol Psychiatry       Date:  2022-06-29       Impact factor: 15.992

2.  1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults.

Authors:  Firat Kara; James M Joers; Dinesh K Deelchand; Young Woo Park; Scott A Przybelski; Timothy G Lesnick; Matthew L Senjem; Burcu Zeydan; David S Knopman; Val J Lowe; Prashanthi Vemuri; Michelle M Mielke; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2022-01-05       Impact factor: 4.673

3.  Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?

Authors:  Sarah J Banks; Murray J Andrews; Leonardino Digma; John Madsen; Emilie T Reas; Jessica Z K Caldwell; Linda K McEvoy; Chun Chieh Fan; Anders M Dale; James B Brewer
Journal:  Neurobiol Aging       Date:  2021-06-04       Impact factor: 5.133

4.  Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology.

Authors:  Ece Bayram; David G Coughlin; Irene Litvan
Journal:  Mov Disord       Date:  2022-05-09       Impact factor: 9.698

Review 5.  Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.

Authors:  Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2021-09-28       Impact factor: 16.655

6.  Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study.

Authors:  Rachel F Buckley; Adrienne O'Donnell; Emer R McGrath; Heidi I L Jacobs; Cristina Lois; Claudia L Satizabal; Saptaparni Ghosh; Zoe B Rubinstein; Joanne M Murabito; Reisa A Sperling; Keith A Johnson; Sudha Seshadri; Alexandra S Beiser
Journal:  Ann Neurol       Date:  2022-05-17       Impact factor: 11.274

7.  Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.

Authors:  Clara Vila-Castelar; Pierre N Tariot; Kaycee M Sink; David Clayton; Jessica B Langbaum; Ronald G Thomas; Yinghua Chen; Yi Su; Kewei Chen; Nan Hu; Margarita Giraldo-Chica; Carlos Tobón; Natalia Acosta-Baena; Ernesto Luna; Marisol Londoño; Paula Ospina; Victoria Tirado; Claudia Muñoz; Eliana Henao; Yamile Bocanegra; Sergio Alvarez; Silvia Rios-Romenets; Valentina Ghisays; Dhruman Goradia; Wendy Lee; Ji Luo; Michael H Malek-Ahmadi; Hillary D Protas; Francisco Lopera; Eric M Reiman; Yakeel T Quiroz
Journal:  Alzheimers Dement       Date:  2022-02-01       Impact factor: 16.655

Review 8.  Protective genes and pathways in Alzheimer's disease: moving towards precision interventions.

Authors:  Mabel Seto; Rebecca L Weiner; Logan Dumitrescu; Timothy J Hohman
Journal:  Mol Neurodegener       Date:  2021-04-29       Impact factor: 14.195

9.  Impact of sex and APOE ε4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults.

Authors:  Kellen K Petersen; Ellen Grober; Richard B Lipton; Reisa A Sperling; Rachel F Buckley; Paul S Aisen; Ali Ezzati
Journal:  Alzheimers Dement (Amst)       Date:  2022-02-09

10.  Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.

Authors:  Lauren Edwards; Renaud La Joie; Leonardo Iaccarino; Amelia Strom; Suzanne L Baker; Kaitlin B Casaletto; Yann Cobigo; Harli Grant; Minseon Kim; Joel H Kramer; Taylor J Mellinger; Julie Pham; Katherine L Possin; Howard J Rosen; David N Soleimani-Meigooni; Amy Wolf; Bruce L Miller; Gil D Rabinovici
Journal:  Neurobiol Aging       Date:  2021-04-22       Impact factor: 5.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.